+ 1 888 391 5441
Sort By
Title Published Price Buy Now
Investigation Report on China's Recombinant Human Follitropin Market, 2018-2022
By China Research and Intelligence
Description As environmental pollution intensifies and Chinese people's lifestyle changes, the incidence of infertility is increasing in China. In 2017, the incidence of infertility among married couples in China was 10%, ...
Jan 2019 $ 2200
Investigation Report on China's Entecavir Market, 2018-2022
By China Research and Intelligence
Description In China, more than 100 billion people are chronically infected with hepatitis B virus (HBV), of which 20 million to 30 million have chronic hepatitis B. It is estimated that every year, more than 500,000 peopl...
Jan 2019 $ 2200
Investigation Report on China's Pancreatic Kininogenase Market, 2018-2022
By China Research and Intelligence
Description The incidence of and the death rate from cardiovascular and cerebrovascular diseases are increasing in China with the development of economy, the change of lifestyle and the aging of the population. It is estim...
Jan 2019 $ 2200
Investigation Report on China's Amlodipine Market, 2018-2022
By China Research and Intelligence
Description The incidence of hypertension is increasing in China with the development of economy, the change of lifestyle and the aging of the population. It is estimated that at the end of 2017, there were about 330 million hypertensi...
Dec 2018 $ 2200
Investigation Report on China's Recombinant Lispro Insulin Market, 2018-2022
By China Research and Intelligence
Description The rapid development of China's economy in the past 30 years has brought about changes in people's lifestyles, for example, the reduction in exercise and the rising intake of calories, which increases the incidence of diab...
Dec 2018 $ 2200
Investigation Report on China's Telmisartan Market, 2018-2022
By China Research and Intelligence
Description By the end of 2017, there were about 330 million hypertensive patients in China, in another word, one in every three adults in China had hypertension. The incidence of hypertension in China rose from 5.1% in 1959 to 37.2% i...
Dec 2018 $ 2200
Investigation Report on China's Insulin Detemir Market, 2018-2022
By China Research and Intelligence
Description In the past three decades, the incidence of diabetes kept rising in China with the aging population, changed dietary habits and reduced physical activities resulting from the rapid economic development. It is estimated that...
Dec 2018 $ 2200
Investigation Report on China's Levofloxacin Market, 2018-2022
By China Research and Intelligence
Description The antibacterial drug segment is the largest and most profitable segment of the global pharmaceuticals market. As antibacterial drugs that develop rapidly in recent years, quinolones are receiving more and more attention f...
Dec 2018 $ 2200
Investigation Report on China's Mecobalamin Market, 2018-2022
By China Research and Intelligence
Description Peripheral neuropathy is a syndrome caused by many factors. Mecobalamin is a peripheral nerve repair agent. Mecobalamin tablets are used to treat peripheral neuropathy and diseases caused by vitamin B12 defic...
Dec 2018 $ 2200
Investigation Report on China's Recombinant Human Lutropin alfa Market, 2018-2022
By China Research and Intelligence
Description According to the WHO's estimate, infertility affects 15% to 20% of the global population. Survey data shows that in 2017, the incidence of infertility among married couples in China was 10%, more than double the 4.8% in 198...
Dec 2018 $ 2200
Investigation Report on China's Loratadine Market, 2018-2022
By China Research and Intelligence
Description The incidences of common skin redness, itching and rashes and respiratory allergies are rising as China's economy develops, the living environment and dietary structure change, and environmental pollution intensifies, which...
Dec 2018 $ 2200
Investigation Report on China’s Montelukast Market, 2018-2022
By China Research and Intelligence
More than 300 million people in the world are suffering from seasonal asthma of varying degrees. The number is higher in countries with severe environmental pollution and high tobacco consumption. Asthma and allergic r...
Nov 2018 $ 2200
Investigation Report on China’s Glimepiride Market, 2018-2022
By China Research and Intelligence
Glimepiride is a third-generation sulfonylurea insulin secretagogue. Sanofi’s brand-name drug (trade name: Amaryl) have been marketed in many countries after it was approved by the FDA (U.S. Food and Drug Adminis...
Nov 2018 $ 2200
Investigation Report on China’s Rosuvastatin Market, 2018-2022
By China Research and Intelligence
Rosuvastatin was first developed by Japanese company Shionogi & Co., Ltd. in the late 1980s. In Jun. 1998, Shionogi & Co., Ltd. transferred the right to develop, market and sell Rosuvastatin worldwide to AstraZ...
Nov 2018 $ 2200
Investigation Report on China's Ambroxol Market, 2018-2022
By China Research and Intelligence
Description The incidence and case fatality rate of respiratory diseases in China are high in recent years. Following cardiovascular and cerebrovascular diseases and cancers, respiratory diseases rank third among the chron...
Nov 2018 $ 2200
Investigation Report on China's Metformin Market, 2018-2022
By China Research and Intelligence
Description The rapid development of the Chinese economy in the past three decades has changed people's dietary habits and reduced physical activities, which leads to an increasing incidence of obesity-related diseases. It...
Nov 2018 $ 2200
Investigation Report on China's Metoprolol Market, 2018-2022
By China Research and Intelligence
Description Estimated according to the population size and structure, there are about 330 million hypertensive patients in China, which means that one in every three adults suffers from hypertension. Chinese hypertensive p...
Nov 2018 $ 2200
Investigation Report on China Entecavir 2018-2022
By China Research and Intelligence
Description The number of people infected with hepatitis B virus (HBV) exceeds 100 million in China, among which 20-30 million suffering from chronic Hepatitis B. About 0.5 million Chinese is estimated to die of liver dama...
Nov 2018 $ 2200
Investigation Report on China's Acarbose Market, 2018-2022
By China Research and Intelligence
Description According to CRI, with improved living standards, ageing population, and increasing obesity rate, the incidence of diabetes has been climbing in China. By the end of 2017, the number of diabetic patients in Chi...
Nov 2018 $ 2200
Investigation Report on China's Insulin Aspart Market, 2018-2022
By China Research and Intelligence
Description The rapid development of the Chinese economy in the past three decades has changed people's dietary habits and reduced physical activities, which leads to an increasing incidence of obesity-related diseases. It...
Nov 2018 $ 2200
Investigation Report on China's Infliximab Market, 2018-2022
By China Research and Intelligence
Description By 2017, there were over 5 million rheumatoid arthritis (RA) patients and over 4 million ankylosing spondylitis patients in China. As the incidence of Crohn's disease rises in recent years, over 100,000 people ...
Oct 2018 $ 2200
Investigation Report on China's Omeprazole Market, 2018-2022
By China Research and Intelligence
Description Gastric ulcer is a common disease worldwide. It is estimated that there are 25 million to 70 million gastric ulcer patients in China. As early as the 1980s, the global market size of gastric ulcer drugs...
Oct 2018 $ 2200
Investigation Report on China's Repaglinide Market, 2018-2022
By China Research and Intelligence
Description Since the 1980s, China's economic development has improved living standards and urbanization level, which significantly increases the incidence of obesity, diabetes and other non-communicable diseases in China....
Oct 2018 $ 2200
China Human Vaccine Industry Report, 2018-2022
By Research In China
As the world’s largest producer of human vaccines, China has established a full-life-cycleregulatory system covering vaccine R&D, production, distribution, and vaccination. The lot release volume of human vaccines has remained at...
Oct 2018 $ 3000
Investigation Report on China's Gliclazide Market, 2018-2022
By China Research and Intelligence
Description The overweight population and the incidence of type 2 diabetes are growing in China as the economy develops, the population ages, and the lifestyle changes. The number of people with type 2 diabetes exceeded 110 million at the end o...
Sep 2018 $ 2200

Buy Any Report Avail 15% Discount. Coupon Code: OCT15

We use cookies to deliver the best possible experience on our website.
By continuing to use this site, or closing this box, you consent to our use of cookies. To learn more, visit our Privacy Policy